The Novavax coronavirus vaccine for people over the age of 18 was approved by the British Drug Regulatory Authority (MHRA) on Thursday. This is the fifth coronavirus vaccine approved in the United Kingdom.
The Nuvaxovid vaccine was licensed for first and second doses after it was found to meet the required safety, quality and efficacy standards, the UK Drugs and Health Products Regulatory Authority said in a statement.
The approval of the vaccine from Britain was received a few days after the pharmaceutical company applied for a license in the US, after months of problems with its development and production.
“We are continuing our vital work to ensure the safety of all coronavirus vaccines to ensure that their benefits for protecting people against Covid-19 continue to outweigh the risks,” said June Raine, MHRA’s CEO. .
Following approval by the MHRA, the Joint Immunization and Vaccination Committee will issue guidelines for the use of the vaccine in the UK coronavirus vaccination program.
They are expected in our country on February 21 the 474,000 doses of the new vaccine against coronavirus Novavax, as the Secretary General of Primary Health Care, Marios Themistokleous, pointed out to SKAI in the meantime.
See all the news
reuters.com
Follow Skai.gr on Google News
and be the first to know all the news
Skai
